Fri, March 4, 2022

Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $54 on, Mar 4th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-54-on-mar-4th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Decreased Target from $55 to $54 on, Mar 4th, 2022.

Robert has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Robert's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Robert


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $29 on, Tuesday, February 1st, 2022
  • Andrew Galler of "Wolfe Research" Initiated at Buy and Held Target at $44 on, Tuesday, November 9th, 2021